
Opinion|Videos|September 4, 2024
Safety and Efficacy of GnRHa Treatments in Central Precocious Puberty
The panel examines the efficacy and safety profiles of gonadotropin-releasing hormone analogue (GnRHa) treatments in managing Central Precocious Puberty.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are long-term efficacy and safety data associated with gonadotropin releasing hormone analogue (GnRHa) treatment?
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
AAP updates guidance on pediatric iron deficiency screening and treatment
2
Pediatric clinical trial update: Q2 2026
3
FDA expands roflumilast cream approval to children as young as 2 years with plaque psoriasis
4
Sequential bilateral TMS linked to improvement in youth treatment-resistant depression
5





